publication venue for
- SCAI/ACR/APMA/SCVS/SIR/SVM/SVS/VESS Position Statement on Competencies for Endovascular Specialists Providing CLTI Care. 2022
- National trends in utilization of thrombolytic therapy for acute pulmonary embolism.. 27. 2021
- Low left ventricular outflow tract velocity time integral is associated with poor outcomes in acute pulmonary embolism.. 25. 2019
- A pulmonary embolism response team's initial 20 month experience treating 87 patients with submassive and massive pulmonary embolism.. 23. 2017
- The Society for Vascular Medicine: the first quarter century.. 20. 2015
- Distribution of calcification in carotid endarterectomy tissues: comparison of micro-computed tomography imaging with histology.. 19. 2014
- Clinical and socioeconomic factors associated with unrecognized peripheral artery disease.. 19. 2014
- The combination of 9p21.3 genotype and biomarker profile improves a peripheral artery disease risk prediction model.. 19. 2013
- The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease.. 17. 2012
- A validated biomarker panel to identify peripheral artery disease.. 17. 2012
- Endovascular correction of cerebrovenous anomalies in multiple sclerosis: a retrospective review of an uncontrolled case series.. 17. 2012
- Sex differences in the prevalence of peripheral artery disease in patients undergoing coronary catheterization.. 15. 2010
- Cholinergic activation of hematopoietic stem cells: role in tobacco-related disease?. 15. 2010
- Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease.. 15. 2010
- Chronic exposure to nicotine impairs cholinergic angiogenesis.. 15. 2009
- Hypercholesterolemia impairs exercise capacity in mice.. 14. 2009
- A biomarker panel for peripheral arterial disease.. 13. 2008
- Measurement characteristics of the ankle-brachial index: results from the Action for Health in Diabetes study.. 13. 2008
- Limb hemodynamics are not predictive of functional capacity in patients with PAD.. 11. 2006
- Limitation of the resting ankle-brachial index in symptomatic patients with peripheral arterial disease.. 11. 2006
- A pilot study of L-arginine supplementation on functional capacity in peripheral arterial disease.. 10. 2005
- Vascular compliance versus flow-mediated vasodilation: correlation with cardiovascular risk factors.. 10. 2005
- Homocysteine-induced vascular dysregulation is mediated by the NMDA receptor.. 10. 2005
- Suboptimal intensity of risk factor modification in PAD.. 10. 2005
- ADMA regulates angiogenesis: genetic and metabolic evidence.. 10. 2005
- Isoflavones improve vascular reactivity in post-menopausal women with hypercholesterolemia.. 9. 2004
- Randomized trial of AT-1015 for treatment of intermittent claudication. A novel 5-hydroxytryptamine antagonist with no evidence of efficacy.. 9. 2004
- Images in vascular ultrasound. Stenosis of the innominate or left common carotid artery origin diagnosed on carotid ultrasound examination.. 8. 2003
- Gender differences in perception of PAD: a pilot study.. 8. 2003
- Adenoviral-mediated gene transfer of vascular endothelial growth factor in critical limb ischemia: safety results from a phase I trial.. 8. 2003
- Proteinuria in a placebo-controlled study of basic fibroblast growth factor for intermittent claudication.. 6. 2001
- Cholesterol-induced upregulation of angiotensin II and its effects on monocyte-endothelial interaction and superoxide production.. 6. 2001
- Effects of stenting on adjacent vascular distensibility and neointima formation: role of nitric oxide.. 6. 2001
- Differential expression of nitric oxide by dermal microvascular endothelial cells from patients with scleroderma.. 5. 2000
- Nutritional therapy for peripheral arterial disease: a double-blind, placebo-controlled, randomized trial of HeartBar.. 5. 2000
- Vascular endothelial growth factor is efficiently synthesized in spite of low transfection efficiency of pSG5VEGF plasmids in vascular smooth muscle cells.. 5. 2000
- L-arginine and nitric oxide-related compounds in plasma: comparison of normal and arginine-free diets in a 24-h crossover study.. 4. 1999
- Role of digital artery adrenoceptors in Raynaud's disease.. 2. 1997
- News from the Society for Vascular Medicine and Biology.. 1. 1996
- Felodipine inhibits intimal lesion formation in the hypercholesterolemic rabbit: differential effects on endothelial and monocyte determinants of atherogenesis.. 1. 1996
- Reduced CT iodine perfusion score is associated with adverse clinical outcomes in acute pulmonary embolism. 2022
- DDAH: a target for vascular therapy?. 15. 2010
- ADMA: an emerging cardiovascular risk factor.. 10 Suppl 1. 2005
- The 1998 Nobel prize in Medicine: clinical implications for 1999 and beyond.. 4. 1999
- Mechanisms of Raynaud's disease. 2005
- Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA. 2005
- Undertreatment of dyslipidemia in peripheral arterial disease and other high-risk populations: an opportunity for cardiovascular disease reduction. 2002
- Outcomes with cilostazol after endovascular therapy of peripheral artery disease. 2019
- Persistent right ventricular dysfunction, functional capacity limitation, exercise intolerance, and quality of life impairment following pulmonary embolism: Systematic review with meta-analysis. 2016